Growth hormone and metabolism (Q39651304)

13 September 2017

1 reference

title

Growth hormone and metabolism (English)

1 reference

13 September 2017

Press M

1

1 reference

13 September 2017

1 June 1988

1 reference

Diabetes/metabolism reviews

13 September 2017

1 reference

13 September 2017

4

1 reference

13 September 2017

4

1 reference

13 September 2017

391-414

1 reference

THE ISOLATION OF PITUITARY GROWTH HORMONE

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Preparation and properties of growth hormone from human and monkey pituitary glands.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The Molecular Nature of Circulating Growth Hormone in Normal and Acromegalic Man: Evidence for a Principal and Minor Monomeric Forms*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone: deletions in the protein and introns in the gene

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human growth hormone DNA sequence and mRNA structure: possible alternative splicing

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Properties of Human Growth Hormone Polypeptides: Purified from Pituitary Extracts and Synthesized in Monkey Kidney Cells and Bacteria

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The 20,000-dalton structural variant of human growth hormone: Lack of some early insulin-like effects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hyperglycemic activity of the 20,000-dalton variant of human growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Variants of growth hormone and prolactin and their posttranslational modifications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Characterization of Growth Hormone of Different Molecular Weights in Rat, Dog and Human Pituitaries

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies on "big" growth hormone from human plasma and pituitary

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies of the Composition and Radioreceptor Activity of “Big” and “Little” Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

A Growth Hormone Binding Protein in Normal Human Serum

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies on the heterogeneity and serum binding of human growth hormone.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

A specific growth hormone-binding protein in human plasma: initial characterization

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Structural Variants of Human Growth Hormone: Biochemical, Genetic, and Clinical Aspects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Metabolic effects of human and monkey growth hormone in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth Hormone and Insulin Binding to Human Liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Reactivity of Non-Primate Growth Hormones and Prolactins with Human Growth Hormone Receptors on Cultured Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Structures of the somatotropin receptor and prolactin receptor on rat hepatocytes characterized by affinity labelling

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Monoclonal Antibodies to the Rabbit Liver Growth Hormone Receptor: Production and Characterization*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Somatomedins (first of two parts).

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Actions of insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hepatic Clearance of Human Growth Hormone1

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Somatomedin Generation by Perfused Livers

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Comparison of Somatomedin Activity in Perfusates of Normal and Hypophysectomized Rat Livers With and Without Added Growth Hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The liver as a source of somatomedin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The Effects of Insulin and Growth Hormone on the Release of Somatomedin by the Isolated Rat Liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Current Concepts of Somatomedin and Other Biologically Related Growth Factors

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Sulfation factor regulation of skeletal growth. A stable mechanism dependent on intermittent growth hormone secretion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factor I stimulates growth in hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone stimulates longitudinal bone growth directly

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factors stimulate synthesis of nucleic acids and glycogen in cultured calvaria cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Dual control of cell growth by somatomedins and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The purification and partial characterization of an insulin-like protein from human serum

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Primary structure of human insulin-like growth factor II.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of insulin-like growth factors on chick embryo hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

2 Plasma forms of somatomedin and the binding protein phenomenon

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier Protein

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Recent advances in the biochemistry and physiology of the insulin-like growth factor/somatomedin family

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Risk of hypoglycaemia with alternate-day growth hormone injections.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hypoglycemia Associated with Non-Islet-Cell Tumor and Insulin-like Growth Factors

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

In VitroStimulation of Leucine Incorporation Into Muscle and Cartilage Protein by a Serum Fraction with Sulfation Factor Activity: Differentiation of Elfects from Those of Growth Hormone and Insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of human somatomedin preparations on membrane transport and protein synthesis in the isolated rat diaphragm.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Dietary components that regulate serum somatomedin-C concentrations in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factors in the fed and fasted states.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

THE RELATION BETWEEN THE GROWTH AND DIABETOGENIC EFFECTS OF THE SO-CALLED GROWTH HORMONE OF THE ANTERIOR PITUITARY.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human pituitary tissue secretes a potent growth factor for chondrocyte proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth Hormone and Lipolysis: A Reevaluation*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

A Hybrid Noncovalent Complex of Fragments of Porcine and Human Growth Hormones with Diabetogenic Activity*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Biological activity of bacterial derived human growth hormone in adipose tissue of hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Rapid effects of growth hormone on amino acid transport and protein synthesis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

SEPARATION OF THE EFFECTS OF GROWTH HORMONE ON MUSCLE AMINO ACID TRANSPORT AND PROTEIN SYNTHESIS

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Antilipolytic effects of growth hormone.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies on the Mechanism of the Antilipolytic Effects of Growth Hormone12

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Comparison of Several Insulin-Like Effects of Growth Hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

ACUTE REDUCTION OF PLASMA NONESTERIFIED FATTY ACID BY GROWTH HORMONE IN HYPOPHYSECTOMIZED AND HOUSSAY RATS

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The antilipolytic, insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

EARLY AND LATE EFFECTS OF GROWTH HORMONE ON THE METABOLISM OF GLUCOSE IN ADIPOSE TISSUE

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effects of growth hormone on carbohydrate and lipid metabolism in the dog

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of insulin and growth hormone on the flux rates of plasma glucose and plasma free fatty acids in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Acute Metabolic Effects of Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Early insulin synergistic activity of growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of Growth Hormone on Glucose Utilization in Diaphragm Muscle in the Absence of Increased Lipolysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone and the metabolism of carbohydrate and lipid in adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of nutritional status and the pituitary on the acute plasma free fatty acid and glucose responses of rats to growth hormone administration.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Some effects of purified pituitary growth hormone on carbohydrate metabolism in the rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hourly variations in plasma concentrations of growth hormone and insulin and in amino acid uptake and incorporation into protein in diaphragm muscle of the rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Rapid modulation of protein synthesis in normal rats by specific neutralization and replacement of growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Influence of growth hormone on splanchnic glucose production in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of growth hormone on glucose metabolism and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

ROLES OF INSULIN AND GROWTH HORMONE, BASED ON STUDIES OF FOREARM METABOLISM IN MAN

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of synthetic fragment 31-44 of human growth hormone on glucose uptake by isolated adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Transmission of conformational change in insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Direct stimulation by growth hormone of glucagon and insulin release from isolated rat pancreas

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Acute suppressive effect of human growth hormone on basal insulin secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

On the diabetogenic effect of growth hormone in man: effects of growth hormone of glucagon and insulin secretion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-Like and Diabetogenic Effects of Growth Hormone in Healthy Subjects, Diabetics, and Low Insulin Responders*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

PLASMA-INSULIN RESPONSE TO SUSTAINED HYPERGLYCEMIA INDUCED BY GLUCOSE INFUSION IN HUMAN SUBJECTS

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Influence of Growth Hormone on Insulin Secretion: Studies of Growth-Hormone Deficient Subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of Growth Hormone, Prolactin, and Placental Lactogen on Insulin Content and Release, and Deoxyribonucleic Acid Synthesis in Cultured Pancreatic Islets

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth Hormone Stimulates Islet B-Cell Replication in Neonatal Rat Pancreatic Monolayer Cultures

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

In VitroEffects of Growth Hormone on the Number and Activity of Ribosomes Engaged in Protein Synthesis in the Isolated Rat Diaphragm1

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Relation of purifies pituitary growth hormone and insulin in regulation of nitrogen balance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Analysis of refractoriness to the effects of growth hormone on amino acid transport and protein synthesis in diaphragms of young normal rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of growth hormone on protein and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hormone-fuel interrelationships during fasting

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Metabolic response to human growth hormone during prolonged starvation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Enzyme regulation in gluconeogenesis and lipogenesis. Relationship of protein synthesis and cyclic AMP to lipolytic action of growth hormone and glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Role of lipolytic and glucocorticoid hormones in the development of diabetic ketosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of growth hormone on the metabolism of lipids and on urea formation by the perfused rat liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The influence of hypophysectomy and of growth hormone administration on the oxidation of palmitate-1-C14 by the unanesthetized rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of growth hormone on plasma fatty acids

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Importance of pituitary hormones in aetiology of diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Pituitary Growth Hormone Essential for Regulation of Serum Cholesterol

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies of hyperlipidemia in the HGH-deficient state.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Serum cholesterol and triglycerides in children with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Absence of an effect of chronic administration of growth hormone on serum lipids

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone in the regulation of hyperlipidemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of thyroxine and growth hormone on the hypercholesterolemia of growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of growth hormone replacement on development of hypothyroidism and hyperlipidemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

A study in the pathogenesis of hyperlipemia in a patient with acromegaly and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Absence of Hyperlipidemia in Acromegaly

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Differentiation of growth hormone from the pituitary factor which produces diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

"Growth" and the Diabetogenic Action of Anterior Pituitary Preparations.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth and Experimental Insulin-insensitive Diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Influence of fasting on changes in glucose metabolism induced by growth hormone injection in the normal dog.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of hypophysectomy on liver enzymes involved in glycogenolysis and in glucogenesis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human growth hormone as a regulator of blood glucose concentration and as a diabetogenic substance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Changes of Carbohydrate Tolerance in Acromegaly with Progress of the Disease and in Response to Treatment

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of human growth hormone in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The diabetogenic action of huuan growth hormone: glucose--fatty acid interrelationships.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Acute effects of exogenous growth hormone in man: time- and dose-bound modification of glucose tolerance and glucose-induced insulin release

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hormonal genesis of glucose intolerance following hypoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of hypoglycaemia on oral glucose tolerance in normal subjects and patients with pituitary and adrenal disorders

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of human growth hormone in hypophysectomised diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of human growth hormone in hypophysectomized human diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of insulin on growth hormone-induced metabolic derangements in diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Profiles of metabolic control in diabetic children-frequency of asymptomatic nocturnal hypoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

In search of the Somogyi effect

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Diabetes, diabetic angiopathy, and growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin-like growth factors. Studies in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Absent sleep peak of growth hormone release in blind subjects: ccorrelation with sleep EEG stages.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Distribution of immunoreactive growth hormone-releasing hormone in the human brain and intestine and its production by tumors.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Inhibition of Endogenous Growth Hormone Secretion by Exogenous Growth Hormone Infusion in the Rhesus Monkey1

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Regulation of Growth Hormone Release: Evidence against Negative Feedback in Rat Pituitary Cells*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of Growth Hormone Excess and Deficiency on Hypothalamic Somatostatin Content and Release and on Tissue Somatostatin Distribution*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of Insulin-Like Growth Factors on Adult Male Rat Pituitary Function in Tissue Culture*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hypoglycemia: a potent stimulus to secretion of growth hormone.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

THE INFLUENCE OF BLOOD GLUCOSE ON THE PLASMA CONCENTRATION OF GROWTH HORMONE.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The Location of the Chemoreceptor Controlling Growth Hormone Secretion during Hypoglycemia in Primates

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of a small decrease in blood-glucose on plasma-growth-hormone and urinary excretion of catecholamines in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Lack of relation between plasma-growth-hormone levels and small decrements in blood-sugar

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Hypoglycemic Threshold for Human Growth Hormone Release

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth-hormone release by glucagon

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Human growth hormone release in sleep: nonsuppression by acute hyperglycemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Insulin suppresses growth hormone secretion by rat pituitary cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Evidence for a Central Abnormality in the Regulation of Growth Hormone Secretion in Insulin-dependent Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effects of Human Growth Hormone in Elderly Males

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Abnormalities of growth hormone regulation in acute intermittent porphyria.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Acute metabolic responses to myocardial infarction. Changes in glucose utilization and secretion of insulin and growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Serum-growth hormone and glucose intolerance in renal failure.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Plasma insulin and growth hormone levels in obesity and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Glucose Counterregulation in Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

PLASMA GROWTH HORMONE RESPONSE TO INTRAVENOUS ADMINISTRATION OF AMINO ACIDS.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of arginine on serum-levels of human growth-hormone.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Arginine-initiated release of human growth hormone. Factors modifying the response in normal man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of food intake on growth-hormone level

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Patterns of hormonal release after glucose, protein, and glucose plus protein.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of lipid and ketone infusions on insulin-induced growth hormone elevations in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Inhibition of sleep related growth hormone release by elevated free fatty acids.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Studies on growth hormone secretion in protein-calorie malnutrition

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth hormone and kwashiorkor. Role of protein in growth-hormone homoeostasis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

High 24-hour level of serum growth hormone in juvenile diabetics.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Integrated concentration of growth hormone in juvenile-onset diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Abnormal growth hormone response to ingestion of glucose in juvenile diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Abnormal serum growth hormone response to exercise in juvenile diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Characteristics of Growth Hormone Secretion in Clinically Stable Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Metabolic clearance rate of growth hormone in juvenile diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Daily production and metabolic clearance of growth hormone in juvenile diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Somatomedin Activity and Diabetic Control in Children with Insulin-Dependent Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth Hormone and Somatomedin in Insulin-Dependent Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Growth Hormone Response to Hyperinsulinaemia in Insulin-dependent Diabetics Comparison of Patients With and Without Retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Changes in plasma growth hormone in diabetic and nondiabetic subjects during the glucose clamp.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF(1-44)] in type 2 (non-insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610040406

7 January 2021

Identifiers

DOI

10.1002/DMR.5610040406

0 references

PubMed ID

3292176

1 reference

PubMed ID

3292176